Illumina launches SpliceAI2 genomic AI model for rare disease variant interpretation
Illumina says SpliceAI2 found 17% more disease-relevant splice variants, but clinical use will require more than stronger AI prediction.
Pharma & Biotech
Pharma & Biotech
Insilico rentosertib makes six proteomic aging clocks trend younger in IPF trial
A Nature Biotechnology analysis of 42 rentosertib-treated IPF trial participants found younger predicted biological-age profiles across six proteomic clocks, but researchers caution that the finding does not prove human aging was reversed.